Amplexa Genetics A/S reposted this
Fenger, Christina Dühring was representing Amplexa Genetics at the exciting and interactive NIHR/MRC mTOR Pathway Diseases node kick-off event in London on November 24th. Here, we had the opportunity to meet with colleagues and potential collaborators, including doctors and researches to discuss the diagnosis of patients with focal epilepsy. During the event, Joseph Mathew Bateman and Laura Mantoan were pleased to announce that they have received a grant of £1.2 million from MRC for research on brain-specific somatic variants in mTOR pathway genes with Amplexa Genetics A/S as a partner 🧠💡 This funding aims to explore the potential development of focal epilepsy. The gathering provided a valuable platform for networking and fostering collaborations in the field of epilepsy research. Amplexa Genetics looks forward to contributing to advancements in understanding and addressing mTOR pathway diseases through ongoing partnerships and research initiatives 🌐🤝 #FocalEpilepsy #Neuroscience #MRCSupport #mTOR
Neuropediatrician and Researcher at the IRCCS E. Medea Scientific Institute
10moCongratulations 😍😍😍🎉🎉🎉💐💐💐